Intractable urinary tract infection in a renal transplant recipient.
Urinary tract infections (UTI) are the most common bacterial infections after renal transplantation and are associated with significant morbidity and mortality. Recurrent or relapsing infections are not uncommon in the early post-transplant period and superadded fungal UTI can occur in these patients, posing a difficult therapeutic problem. Literature on recurrent UTI after transplant as well as the ideal approach to such patients is scanty. We present the case of a renal allograft recipient who presented with relapsing bacterial UTI complicated by systemic fungemia; also, a brief review of fungal UTI is attempted.
Satish
Renuka
R
Department of Nephrology, St. John's Medical College Hospital, Bangalore, India. renuka_nephro@yahoo.com
Gokulnath
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D041221:Candida glabrata / Q000302:isolation & purification*; D004926:Escherichia coli / Q000302:isolation & purification*; D017809:Fatal Outcome; D006801:Humans; D007674:Kidney Diseases / Q000382:microbiology* / Q000628:therapy; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D009181:Mycoses / Q000382:microbiology* / Q000628:therapy; D009392:Nephrectomy; D012008:Recurrence; D012086:Reoperation; D014184:Transplantation, Homologous; D014552:Urinary Tract Infections / Q000382:microbiology* / Q000628:therapy; D014556:Urine / Q000382:microbiology; D055815:Young Adult
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents